Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647

Roberto Russo, Jesse LoVerme, Giovanna La Rana, Giuseppe D'Agostino, Oscar Sasso, Antonio Calignano, Daniele Piomelli

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The analgesic properties of cannabinoid receptor agonists are well characterized. However, numerous side effects limit the therapeutic potential of these agents. Here we report a synergistic antinociceptive interaction between the endogenous cannabinoid receptor agonist anandamide and the synthetic peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist 2-(4-(2-(1-Cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid (GW7647) in a model of acute chemical-induced pain. Moreover, we show that anandamide synergistically interacts with the large-conductance potassium channel (KCa1.1, BK) activator isopimaric acid. These findings reveal a synergistic interaction between the endocannabinoid and PPAR-alpha systems that might be exploited clinically and identify a new pharmacological effect of the BK channel activator isopimaric acid.
Original languageEnglish
Pages (from-to)117-119
Number of pages3
JournalEuropean Journal of Pharmacology
Volume566
Issue number1-3
Early online date19 Mar 2007
DOIs
Publication statusPublished - 2 Jul 2007

Fingerprint

Cannabinoid Receptor Agonists
PPAR alpha
Isobutyrates
Large-Conductance Calcium-Activated Potassium Channels
Chemical Models
Endocannabinoids
Potassium Channels
Therapeutic Uses
Analgesics
Pharmacology
Pain
anandamide
isopimaric acid
GW 7647

Keywords

  • Analgesics
  • Animals
  • Arachidonic Acids
  • Behavior, Animal
  • Butyrates
  • Cannabinoid Receptor Agonists
  • Drug Synergism
  • Endocannabinoids
  • Formaldehyde
  • Male
  • Mice
  • PPAR alpha
  • Pain
  • Phenylurea Compounds
  • Polyunsaturated Alkamides
  • Cannabinoid
  • Palmitoylethanolamide
  • Isopimaric acid
  • Formalin

Cite this

Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. / Russo, Roberto; LoVerme, Jesse; La Rana, Giovanna; D'Agostino, Giuseppe; Sasso, Oscar; Calignano, Antonio; Piomelli, Daniele.

In: European Journal of Pharmacology, Vol. 566, No. 1-3, 02.07.2007, p. 117-119.

Research output: Contribution to journalArticle

Russo, R, LoVerme, J, La Rana, G, D'Agostino, G, Sasso, O, Calignano, A & Piomelli, D 2007, 'Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647', European Journal of Pharmacology, vol. 566, no. 1-3, pp. 117-119. https://doi.org/10.1016/j.ejphar.2007.03.007
Russo, Roberto ; LoVerme, Jesse ; La Rana, Giovanna ; D'Agostino, Giuseppe ; Sasso, Oscar ; Calignano, Antonio ; Piomelli, Daniele. / Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. In: European Journal of Pharmacology. 2007 ; Vol. 566, No. 1-3. pp. 117-119.
@article{84f2e8b6762540d9a707b0f06b44d208,
title = "Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647",
abstract = "The analgesic properties of cannabinoid receptor agonists are well characterized. However, numerous side effects limit the therapeutic potential of these agents. Here we report a synergistic antinociceptive interaction between the endogenous cannabinoid receptor agonist anandamide and the synthetic peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist 2-(4-(2-(1-Cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid (GW7647) in a model of acute chemical-induced pain. Moreover, we show that anandamide synergistically interacts with the large-conductance potassium channel (KCa1.1, BK) activator isopimaric acid. These findings reveal a synergistic interaction between the endocannabinoid and PPAR-alpha systems that might be exploited clinically and identify a new pharmacological effect of the BK channel activator isopimaric acid.",
keywords = "Analgesics, Animals, Arachidonic Acids, Behavior, Animal, Butyrates, Cannabinoid Receptor Agonists, Drug Synergism, Endocannabinoids, Formaldehyde, Male, Mice, PPAR alpha, Pain, Phenylurea Compounds, Polyunsaturated Alkamides, Cannabinoid, Palmitoylethanolamide, Isopimaric acid, Formalin",
author = "Roberto Russo and Jesse LoVerme and {La Rana}, Giovanna and Giuseppe D'Agostino and Oscar Sasso and Antonio Calignano and Daniele Piomelli",
year = "2007",
month = "7",
day = "2",
doi = "10.1016/j.ejphar.2007.03.007",
language = "English",
volume = "566",
pages = "117--119",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647

AU - Russo, Roberto

AU - LoVerme, Jesse

AU - La Rana, Giovanna

AU - D'Agostino, Giuseppe

AU - Sasso, Oscar

AU - Calignano, Antonio

AU - Piomelli, Daniele

PY - 2007/7/2

Y1 - 2007/7/2

N2 - The analgesic properties of cannabinoid receptor agonists are well characterized. However, numerous side effects limit the therapeutic potential of these agents. Here we report a synergistic antinociceptive interaction between the endogenous cannabinoid receptor agonist anandamide and the synthetic peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist 2-(4-(2-(1-Cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid (GW7647) in a model of acute chemical-induced pain. Moreover, we show that anandamide synergistically interacts with the large-conductance potassium channel (KCa1.1, BK) activator isopimaric acid. These findings reveal a synergistic interaction between the endocannabinoid and PPAR-alpha systems that might be exploited clinically and identify a new pharmacological effect of the BK channel activator isopimaric acid.

AB - The analgesic properties of cannabinoid receptor agonists are well characterized. However, numerous side effects limit the therapeutic potential of these agents. Here we report a synergistic antinociceptive interaction between the endogenous cannabinoid receptor agonist anandamide and the synthetic peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist 2-(4-(2-(1-Cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid (GW7647) in a model of acute chemical-induced pain. Moreover, we show that anandamide synergistically interacts with the large-conductance potassium channel (KCa1.1, BK) activator isopimaric acid. These findings reveal a synergistic interaction between the endocannabinoid and PPAR-alpha systems that might be exploited clinically and identify a new pharmacological effect of the BK channel activator isopimaric acid.

KW - Analgesics

KW - Animals

KW - Arachidonic Acids

KW - Behavior, Animal

KW - Butyrates

KW - Cannabinoid Receptor Agonists

KW - Drug Synergism

KW - Endocannabinoids

KW - Formaldehyde

KW - Male

KW - Mice

KW - PPAR alpha

KW - Pain

KW - Phenylurea Compounds

KW - Polyunsaturated Alkamides

KW - Cannabinoid

KW - Palmitoylethanolamide

KW - Isopimaric acid

KW - Formalin

U2 - 10.1016/j.ejphar.2007.03.007

DO - 10.1016/j.ejphar.2007.03.007

M3 - Article

C2 - 17434479

VL - 566

SP - 117

EP - 119

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -